Table 4 Pathologic examination, stage and follow-up and adjuvant therapy
Pathology | Age (years) | Mean age | Sex | Incidence | Stage | Diagnostics during follow-up | Adjuvant therapy |
|---|---|---|---|---|---|---|---|
Low-grade mucinous appendiceal neoplasia (LAMN, n = 3) | 32 | 51.3 | M | 0.7% | pTis R0 | sonography after 6 months |  |
62 | Â | F | Â | pT4a pM0, Stadium IIB | diagnostic laparoscopy | Â | |
60 | Â | F | Â | pTis | colonoscopy and diagnostic laparoscopy | Â | |
Sessile serrated adenoma of the appendix (n = 3) | 28 | 35.7 | F | 0.7% | no dysplasia | no follow-up |  |
39 | Â | F | Â | no dysplasia | no follow-up | Â | |
40 | Â | F | Â | no dysplasia | colonoscopy | Â | |
Neuroendocrine tumours (n = 7) | 20 | 39.3 | M | 1.5% | pT3 pNx V0 L0 Pn0 G1 R1 |  | right hemicolectomy |
41 | Â | M | Â | pT3a L0 V0, G1 | Â | right hemicolectomy | |
27 | Â | M | Â | pT4 L1 V0 Pn0 RX | DOTATATE-PET-CT, gastroscopy, colonoscopy, diagnostic laparoscopy and biopsy | Â | |
50 | Â | M | Â | pT4 pN2 (4/17) pM1b (PER) L1 V0 Pn0 G1 R0 | DOTATATE-PET-CT | simultaneous right hemicolectomy, partial resection omentum majus, peritonectomy, palliative treatment | |
24 | Â | M | Â | pT1 pNx L0 V0 Pn0 G1 R0 | DOTATATE-PET-CT | Â | |
52 | Â | F | Â | pT1 pNx L0 V0 Pn0 G1 R0 | no follow-up | Â | |
61 | Â | M | Â | pT1 pNx L0 V0 | no follow-up | Â | |
Appendiceal adenocarcinoma from intestinal type (n = 3) | 90 | 74.0 | F | 0.7% | pT4b pN1b (2/17) L1 V0 Pn0 G2 R1 | Exitus letalis (septic shock) | simultaneous right hemicolectomy |
69 | Â | F | Â | pT3 pNx L0 V0 Pn0 G2 R1 | Â | palliative chemotherapy | |
63 | Â | M | Â | pT4a pNx L1 V0 Pn1 G2 R0 | Â | hemicolectomy, lymphadenectomy and adjuvant chemotherapy proposed, but not applied due to poor general condition and patient refusal | |
Goblet cell carcinoma (n = 1) | 54 |  | F |  | pT3 pN0 (0/10) L0 V0 Pn1 G2 R0 | CT-scan and colonoscopy | right hemicolectomy a few weeks later, bilateral ovarectomy during follow-up |